BioLASCO Taiwan Balance Sheet Health
Financial Health criteria checks 5/6
BioLASCO Taiwan has a total shareholder equity of NT$461.2M and total debt of NT$56.6M, which brings its debt-to-equity ratio to 12.3%. Its total assets and total liabilities are NT$573.1M and NT$112.0M respectively. BioLASCO Taiwan's EBIT is NT$50.8M making its interest coverage ratio -94.5. It has cash and short-term investments of NT$201.7M.
Key information
12.3%
Debt to equity ratio
NT$56.61m
Debt
| Interest coverage ratio | -94.5x |
| Cash | NT$201.67m |
| Equity | NT$461.16m |
| Total liabilities | NT$111.98m |
| Total assets | NT$573.14m |
Recent financial health updates
Recent updates
We Think You Should Be Aware Of Some Concerning Factors In BioLASCO Taiwan's (GTSM:6662) Earnings
Apr 01
Are BioLASCO Taiwan Co., Ltd.'s (GTSM:6662) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Mar 11Investors In BioLASCO Taiwan Co., Ltd. (GTSM:6662) Should Consider This, First
Feb 10
Is BioLASCO Taiwan (GTSM:6662) A Risky Investment?
Jan 08BioLASCO Taiwan Co., Ltd.'s (GTSM:6662) Stock Has Shown A Decent Performance: Have Financials A Role To Play?
Dec 10Financial Position Analysis
Short Term Liabilities: 6662's short term assets (NT$289.8M) exceed its short term liabilities (NT$60.1M).
Long Term Liabilities: 6662's short term assets (NT$289.8M) exceed its long term liabilities (NT$51.9M).
Debt to Equity History and Analysis
Debt Level: 6662 has more cash than its total debt.
Reducing Debt: 6662's debt to equity ratio has increased from 3.1% to 12.3% over the past 5 years.
Debt Coverage: 6662's debt is well covered by operating cash flow (52%).
Interest Coverage: 6662 earns more interest than it pays, so coverage of interest payments is not a concern.